Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Geoffrey B. Pelz, a thoracic surgeon at Hackensack College Medical Heart in New Jersey, highlighted the influence of recent surgical advances on...
Dr. Michael Wagner covers the fundamentals of epithelioid hemangioendothelioma, a uncommon vascular most cancers, spanning signs, analysis, remedy choices and extra.Epithelioid hemangioendothelioma (EHE),...
CURE spoke with a thoracic surgeon in regards to the influence of minimally invasive surgical procedure for sufferers.For sufferers with lung most cancers,...
The U.S. FDA has granted quick observe designation to therapy with CLD-201, an oncolytic virus, for sufferers with delicate tissue sarcoma.The U.S. Meals...
